Literature DB >> 12386795

[Leptospirosis as a differential diagnosis of acute renal failure].

Martin Brueck1, Erika Grempels, Georg Braig, Wilfried Kramer.   

Abstract

BACKGROUND: Leptospirosis is a worldwide infectious disease affecting both animals and humans. Leptospira pomona is well known as a pathogen of a mild form of leptospirosis (maladie des jeune porchers). CASE REPORT: A 51-year-old male farmer was referred to our hospital with high fever, hyperbilirubinemia and acute renal failure. Further laboratory tests revealed elevated inflammatory parameters, thrombocytopenia, signs of a mild hepatitis and involvement of pancreas. About 7 days before he had experienced muscle pain accompanied by headache and fever. Suspecting leptospirosis an intravenous therapy with penicillin was started. During the subsequent course of his illness a sixfold increase increase of antibody titer against leptospira pomona was documented within 3 weeks. Urine retention parameters decreased by intravenous fluid resuscitation in the intensive care unit, so that hemodialysis was not necessary. Platelets and bilirubin returned to normal. Atrial fibrillation as a sign of cardiac manifestation of leptospirosis changed spontaneously in a regular and permanent sinusrhythm. The patient was discharged home after 3 weeks in the hospital.
CONCLUSION: Early diagnosis is most important for the prognosis of patients with severe form of leptospirosis. Leptospira pomona is a known pathogen of anicteric leptospirosis but in some cases is able to cause a severe form of leptospirosis with renal failure, jaundice and thrombocytopenia.

Entities:  

Mesh:

Year:  2002        PMID: 12386795     DOI: 10.1007/s00063-002-1202-4

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  1 in total

1.  ["Peculiar infection" with fever, splenomegaly and acute kidney failure in a 24-year-old forestry student].

Authors:  F Strutz; A Scheel; M Koziolek; T Kochsiek; H Eiffert; G A Müller
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.